Emicizumab
Product Specifications
CAS Number
1610943-06-0
Target
Factor V, , Others
Related Pathways
Others, Metabolism
Purity
0.981
Bioactivity
Emicizumab (ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1091232-01 250 mg
2-bromo-4- (tert-butyl) -1- ((3-methylbenzyl) oxy) benzene
Sign In for Pricing
View Details OR1091232-02 500 mg
2-bromo-4- (tert-butyl) -1- ((3-methylbenzyl) oxy) benzene
Sign In for Pricing
View Details OR1091232-03 1 g
2-bromo-4- (tert-butyl) -1- ((3-methylbenzyl) oxy) benzene
Sign In for Pricing
View Details OR1091232-04 5 g
2-bromo-4- (tert-butyl) -1- ((3-methylbenzyl) oxy) benzene
Sign In for Pricing
View Details OR1091232-05 10 g
2-bromo-4- (tert-butyl) -1- ((3-methylbenzyl) oxy) benzene
Sign In for Pricing
View Details